Sirona Dx Announces Partnership with Scailyte for AI driven end-point specific single cell analysis
Scailyte, a single-cell biomarker discovery company and Sirona Dx, a leader in multiomic single-cell analytical services, announce a strategic partnership to accelerate the development of Advanced Therapies. The companies will create a powerful biomarker discovery engine, leveraging Sirona Dx technical and laboratory workflow solutions in combination with Scailyte’s AI-driven data analytics platform ScaiVision™ to serve […]
Ultivue Announces Co-Marketing Agreement with Sirona Dx for Multiplexed Tissue Biomarker Solutions
Ultivue Announces Co-Marketing Agreement with Sirona DX for Multiplexed Tissue Biomarker Solutions for Precision Medicine CAMBRIDGE, Mass. & PORTLAND, Ore.–(BUSINESS WIRE)–Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Sirona Dx, a technical contract research organization (CRO), providing advanced, single cell proteomics and genomics services to […]
Sirona Dx recognized as a Top 10 CRO of 2021 by Medhealth Outlook
The development of innovative immunotherapy approaches for cancers and autoimmune disorders among others, remains a top priority for Biopharma however numerous challenges create hurdles to progress. To begin with, there is a requirement for multi-faceted, high-parameter, single cell readouts from limited sample inputs to identify informative biomarker signatures. Furthermore, the complex nature of the underlying […]
Sirona Dx presents at Fluidigm Virtual Mass Cytometry Investor Day
Dr. Nasry Yassa, CEO and Andrew Brown, Chief Commercial Officer, discuss the use of Fluidigm Mass Cytometry technology within their specialty contract research organization. They have created a specialized CRO business that partners with biopharma to accelerate drug development work, with a focus on introducing novel technologies into early clinical stage development. At this event […]
Sirona Dx Launches Rapid Saliva Based PCR COVID-19 Testing Service Utilizing Advanced Microfluidics
We have implemented advanced microfluidics technology to enable rapid, accurate, lower cost COVID-19 testing on easy to collect saliva samples. The Advanta™ SARS-CoV-2 RT-PCR assay was developed by Fluidigm and is supported by an EUA. The assay is a reverse transcription and real-time polymerase chain reaction (RT-PCR) test that leverages Fluidigm microfluidics technology with the […]
About Sirona Dx
Sirona Dx is a CLIA accredited technical CRO, founded to accelerate the pace of immunotherapy and targeted therapy development. Bridging silos between life science tools developers and translational clinical research, our laboratory offers specialized high complexity single cell proteomics and genomics services to support drug discovery and development programs.
Lunaphore and CRO Sirona Dx collaborate to expand COMET offerings to US-based biotech and biopharma customers
LAUSANNE, Switzerland and PORTLAND, OR, USA– February 23, 2023 – 5:00 pm (CET) | 8 am (PST) – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Sirona Dx, a leader in multi-omics, single-cell analytical services, today announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research […]